Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-01-10 @ 2:57 PM
Study NCT ID:
NCT01851551
Status:
COMPLETED
Last Update Posted:
2020-01-03
First Post:
2013-04-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1/2 Study of VSLI Plus Rituximab in Patients With Relapsed and/or Refractory NHL
Sponsor:
Acrotech Biopharma Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-09
Start Date Type:
None
Primary Completion Date:
2004-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-04
Completion Date Type:
ACTUAL
First Submit Date:
2013-04-29
First Submit QC Date:
None
Study First Post Date:
2013-05-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-31
Last Update Post Date:
2020-01-03
Last Update Post Date Type:
ACTUAL